2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$3.99+$0.11 (+2.97%)
Price as of Oct 22, 2026 7:47 PM EDT- $107.8MMarket Cap
- -20.86%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$3.99+$0.11 (+2.97%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 5.16% | 1.4M | +1.4M (+97.46%) | Jun 30, 2026 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 5.12% | 1.4M | +462,245 (+32.98%) | Jun 30, 2026 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.91% | 1.1M | +260,051 (+24.27%) | Jun 30, 2026 |
OCTAGON CAPITAL ADVISORS LP | 3.65% | 1.0M | 0 (0.00%) | Jun 30, 2026 |
N/A | 2.96% | 811,430 | +811,430 (+100.00%) | Mar 31, 2026 |
DIADEMA PARTNERS LP | 2.89% | 792,600 | +792,600 (+100.00%) | Jun 30, 2026 |
VANGUARD GROUP INC | 2.88% | 788,587 | +129,709 (+16.45%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.82% | 1.0M | +252,977 (+24.19%) | Jun 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.98% | 268,848 | +244,337 (+90.88%) | Jul 31, 2026 |
Dimensional ETF Trust | 0.30% | 82,568 | 0 (0.00%) | Jul 31, 2026 |
EQ ADVISORS TRUST | 0.23% | 64,107 | +64,107 (+100.00%) | Jun 30, 2026 |
SCHWAB CAPITAL TRUST | 0.20% | 54,842 | +54,842 (+100.00%) | Jul 31, 2026 |
QUANTITATIVE MASTER SERIES LLC | 0.17% | 45,675 | +45,675 (+100.00%) | Jun 30, 2026 |
TIAA-CREF FUNDS | 0.12% | 33,059 | +33,059 (+100.00%) | Jul 31, 2026 |
Current Ownership Distribution
- Institutions281.3M (93.45%)
- Mutual Funds16.4M (5.46%)
- Insiders3.3M (1.09%)
- Other0 (0.00%)
Insider Transactions
- 1.09% (3.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Gupta Shalabh K. CEO | Award | Jul 28, 2025 | $0.00 | 325,000 | $0.00 | 968,951 |
Kenkare-Mitra Sara | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 39,200 |
Aggarwal Gaurav | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 39,200 |
Laumas Sandeep | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 41,286 |
Jermasek Douglas EVP of Corporate Strategy | Award | Jul 28, 2025 | $0.00 | 10,000 | $0.00 | 215,500 |
Gupta Pramod EVP, Pharmaceuticals and BD | Award | Jul 28, 2025 | $0.00 | 90,000 | $0.00 | 301,986 |
Townsend John Chief Financial Officer | Award | Jul 28, 2025 | $0.00 | 10,000 | $0.00 | 101,557 |
Aggarwal Gaurav | Return | Feb 18, 2025 | $686,000.00 | 686 | $1,000.00 | 3,119 |
Aggarwal Gaurav | Conversion | Feb 18, 2025 | $0.00 | 1.4M | $0.00 | 11.4M |